ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (Nasdaq: ASBP) ("Aspire" or the "Company"), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026.
DATE: June 25th
TIME: 2:00 pm ET
Available for 1x1 meetings: June 24-25. Schedule 1x1 Meetings here .
The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com .
Company Highlights
Multiple ℞ applications in heart attack/stroke, anti-anxiety, antiplatelet, nausea and others
Large Addressable Markets for ℞ and Supplements
Focused on commercialization through partnerships, licensing and internal development
Omnibus patent and four provisional patents filed for approved therapeutics in multi-billion-dollar markets
Lead Drug Candidate High Dose Aspirin Prescription Product: Trial demonstrated dramatically higher and more rapid therapeutic impact compared to standard chewed aspirin tablets, safe and well-tolerated which is critical during suspected heart attacks, when clots blocking heart arteries can cause permanent muscle damage.
BUZZ BOMB™, New Caffeine Product: Commercial revenue in 2025 with new e-commerce website, packaging and product launched January 2026
Proposed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue expected to close Q3 (unaudited)
About Virtual Investor Conferences ®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma delivers supplements to the body rapidly and precisely.
For more information, please visit www.aspirebiolabs.com
.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com
